[Postmarketing herbs clinical evaluation should concern about re-evaluating symptoms]

Zhongguo Zhong Yao Za Zhi. 2010 Jun;35(11):1498-500.
[Article in Chinese]

Abstract

Re-evaluation of premarketing medicine is a important supplementary of clinical and elementary research. It is a basement that establish the medicine administration supervisition , found and integrity postmarketing washing out mechanism and define reasonable using drug. After drug marketing, we must not only concern on the re-evaluation of herbs security but also focus on evaluating herbs suitable symptom, as well as its dosage and course of treatment, ect. The re-evaluation of symptoms were seen as the core and feature of traditional Chinese medicine's clinical evaluation. It is also seen as hot spot and difficulty of the research . This article try to focus on simply illustrating the necessity and research thinking of re-evaluation symptoms of postmarketing herbs. So we can define the re-evaluation of postmarketing drug's objection, method, and basement. It will provide beneficial experience and reference to re-evaluation symptom of marketed herbs.

Publication types

  • English Abstract

MeSH terms

  • China
  • Clinical Trials as Topic
  • Drug Therapy / standards*
  • Drug-Related Side Effects and Adverse Reactions
  • Drugs, Chinese Herbal / adverse effects
  • Drugs, Chinese Herbal / standards*
  • Drugs, Chinese Herbal / therapeutic use*
  • Humans
  • Product Surveillance, Postmarketing*

Substances

  • Drugs, Chinese Herbal